ATRC (AtriCure) E10: $-0.72 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ATRC AtriCure Inc ATRC
78 GF Score
Price $41.39
GF Value $39.38
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is AtriCure E10?

AtriCure ATRC +4.78% 78 E10 is $-0.72 as of Jun. 2026. GuruFocus rates ATRC with a GF Score™ of 78/100 and a GF Value™ of $39.38 (Fairly Valued). The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

AtriCure's adjusted earnings per share data for the three months ended in Jun. 2026 was $0.180. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-0.72 for the trailing ten years ended in Jun. 2026.

During the past 3 years, the average E10 Growth Rate was 1.30% per year. During the past 5 years, the average E10 Growth Rate was -1.00% per year. During the past 10 years, the average E10 Growth Rate was -0.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of AtriCure was 21.10% per year. The lowest was -6.60% per year. And the median was 1.30% per year.

As of today (2026-08-08), AtriCure's current stock price is $41.39. AtriCure's E10 for the quarter that ended in Jun. 2026 was $-0.72. AtriCure's Shiller PE Ratio of today is .


AtriCure  (NAS:ATRC) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


AtriCure E10 Related Terms


AtriCure E10 Historical Data

* Premium members only.

The historical data trend for AtriCure's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AtriCure E10 Chart

AtriCure Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.71 -0.80 -0.82 -0.86 -0.77

AtriCure Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.85 -0.83 -0.77 0.00 -0.72

ATRC vs BLFS, PLSE, LMAT: E10 Comparison

For the Medical Instruments & Supplies subindustry, AtriCure's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AtriCure Shiller PE Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AtriCure's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where AtriCure's Shiller PE Ratio falls into.


ATRC
78GF Score
AtriCure Inc ATRC
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AtriCure E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, AtriCure's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.18/333.9520*333.9520
=0.180

Current CPI (Jun. 2026) = 333.9520.

AtriCure Quarterly Data

per share eps CPI Adj_EPS
201609 -0.210 241.428 -0.290
201612 -0.270 241.432 -0.373
201703 -0.320 243.801 -0.438
201706 -0.210 244.955 -0.286
201709 -0.220 246.819 -0.298
201712 -0.080 246.524 -0.108
201803 -0.310 249.554 -0.415
201806 -0.010 251.989 -0.013
201809 -0.220 252.439 -0.291
201812 -0.090 251.233 -0.120
201903 -0.150 254.202 -0.197
201906 -0.110 256.143 -0.143
201909 -0.250 256.759 -0.325
201912 -0.420 256.974 -0.546
202003 -0.420 258.115 -0.543
202006 -0.200 257.797 -0.259
202009 -0.110 260.280 -0.141
202012 -0.420 260.474 -0.538
202103 -0.380 264.877 -0.479
202106 -0.360 271.696 -0.442
202109 2.110 274.310 2.569
202112 -0.300 278.802 -0.359
202203 -0.330 287.504 -0.383
202206 -0.320 296.311 -0.361
202209 -0.270 296.808 -0.304
202212 -0.090 296.797 -0.101
202303 -0.140 301.836 -0.155
202306 -0.110 305.109 -0.120
202309 -0.200 307.789 -0.217
202312 -0.210 306.746 -0.229
202403 -0.280 312.332 -0.299
202406 -0.170 314.175 -0.181
202409 -0.170 315.301 -0.180
202412 -0.330 315.605 -0.349
202503 -0.140 319.799 -0.146
202506 -0.130 322.561 -0.135
202509 -0.010 324.800 -0.010
202512 0.040 324.054 0.041
202603 0.000 330.213 0.000
202606 0.180 333.952 0.180

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of $-0.72 mean?
AtriCure (ATRC) has a E10 of $-0.72 as of Jun. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on AtriCure and its competitors.
Is AtriCure's E10 too high?
AtriCure's current E10 is $-0.72. Overall, AtriCure has a GF Score™ of 78/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does AtriCure's E10 compare to BLFS and PLSE?
AtriCure's E10 of $-0.72 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Medical Devices & Instruments company?
A good E10 depends on the Medical Devices & Instruments industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on AtriCure and its competitors. AtriCure's current E10 is $-0.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AtriCure stock overvalued right now?
Based on GuruFocus' analysis, AtriCure (ATRC) is currently considered Fairly Valued. The stock's GF Value™ is $39.38, compared to a current price of $41.39 — trading 5.1% above its estimated fair value. The current E10 is $-0.72. AtriCure's overall GF Score™ is 78/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For AtriCure (ATRC), the current E10 is $-0.72 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is AtriCure (ATRC) Overvalued in 2026?

Based on GuruFocus' analysis, AtriCure stock appears to be overvalued. The current stock price of $41.39 is trading 5.1% above its estimated GF Value™ of $39.38. GuruFocus considers AtriCure to be Fairly Valued.

Key valuation signals for ATRC:

  • E10: $-0.72
  • GF Value™: $39.38 vs. price of $41.39 (5.1% above fair value)
  • GF Score™: 78/100 with 7 warning signs

No single metric tells the full story. See the ATRC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


AtriCure Business Description

Other Exchanges A5I:Germany
Address 7555 Innovation Way, Mason, OH, USA, 45040
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
78GF Score

Get the complete analysis for ATRC

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$41.39
Price
$39.38
GF Value